Panagiotis Repoussis

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care.

M. Dimopoulos, M. Angelopoulou, G. Pangalis, 2012, The oncologist.

Acute Promyelocytic Leukemia: an Experience on 95 Greek Patients Treated in the All-Trans-Retinoic Acid Era

K. Manola, P. Tsirigotis, C. Prokopiou, 2011, Mediterranean journal of hematology and infectious diseases.

Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study.

E. Papageorgiou, E. Bouza, E. Giamarellos‐Bourboulis, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2015, Blood.

Primary treatment of Waldenström macroglobulinemia with dexamethasone, rituximab, and cyclophosphamide.

M. Dimopoulos, M. Kyrtsonis, A. Vassou, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years

M. Dimopoulos, K. Konstantopoulos, T. Economopoulos, 2010, American journal of hematology.

Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH).

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2009, Leukemia research.

Prognostication in young and old patients with Waldenström's macroglobulinemia: importance of the International Prognostic Scoring System and of serum lactate dehydrogenase.

M. Dimopoulos, E. Kastritis, A. Vassou, 2009, Clinical lymphoma & myeloma.

Macrofocal multiple myeloma in young patients: A distinct entity with favorable prognosis

M. Dimopoulos, E. Terpos, A. Anagnostopoulos, 2005, Leukemia & lymphoma.

Veno-occlusive Disease of the Liver after Blood and Marrow Transplantation: Analysis of Pre- and Post-transplant Risk Factors Associated with Severity and Results of Therapy with Tissue Plasminogen Activator

K. Batts, P. Anderson, A. Tefferi, 2002, Leukemia & lymphoma.

Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.

M. Dimopoulos, M. Kyrtsonis, A. Vassou, 2006, Haematologica.

Clinical characteristics and outcome of primary systemic light-chain amyloidosis in Greece.

M. Dimopoulos, E. Kastritis, M. Kyrtsonis, 2010, Clinical lymphoma, myeloma & leukemia.

Primary Treatment with Pulsed Melphalan, Dexamethasone, Thalidomide (MDT) for Symptomatic Patients with Multiple Myeloma ≥ 75 Years of Age.

M. Dimopoulos, A. Vassou, E. Katodritou, 2004 .